Question 1

Does Renaissance Technologies own CLGN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Renaissance Technologies holds 61,500 shares of CLGN (Collplant Biotechnologies), worth $21,457.

Question 2

How many shares of CLGN does Renaissance Technologies own?

Accepted Answer

As of its Q2 2026 13F, Renaissance Technologies holds 61,500 shares of CLGN (Collplant Biotechnologies).

Question 3

What is Renaissance Technologies' CLGN position worth?

Accepted Answer

As of its Q2 2026 13F, Renaissance Technologies' CLGN position is worth $21,457.

Question 4

Is Renaissance Technologies buying or selling CLGN?

Accepted Answer

In Q2 2026, Renaissance Technologies increased its CLGN position from 16,800 to 61,500 shares.

Question 5

When did Renaissance Technologies first buy CLGN?

Accepted Answer

Renaissance Technologies first reported CLGN in its Q3 2021 13F and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	61,500	+266.1%	$21,457	0.0%	$0.35	21
2026-Q1	Decreased	16,800	-4.5%	$9,005	0.0%	$0.57	0
2025-Q4	Decreased	17,600	-19.6%	$24,640	0.0%	$1.40	0
2025-Q3	Decreased	21,900	-47.4%	$58,911	0.0%	$3.09	0
2025-Q2	Increased	41,600	+303.9%	$56,576	0.0%	$1.38	33
2025-Q1	Decreased	10,300	-2.8%	$26,574	0.0%	$2.55	0
2024-Q4	New	10,600	-	$38,160	0.0%	$3.63	28

CLGNShowing 7 of 9 quarters

CLGN
Showing 7 of 9 quarters